packageAfatinib

afatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Afatinib is a protein kinase inhibitor used to treat non-small-cell lung cancer. It is authorised in the European Union for this indication.

Summary written by glm-5.3-flash from Wikidata Q4688818 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:afatinib
ATC codes:L01EB03, L01XE13
DrugBank:DB08916
PubChem CID:10184653
ChEBI:61390
Wikidata:Q4688818
formula:C24H25ClFN5O3
molar mass:485.944 g/mol (PubChem CID 10184653)
logP:3.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown